Vtvt股票zacks

Zacks Investment Research upgraded shares of vTv Therapeutics (NASDAQ:VTVT) from a sell rating to a hold rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. 查看最新的 vTv Therapeutics Inc. (VTVT) 股票報價、記錄、新聞及其他重要資訊，助你賣買股票及投資。 vTv Therapeutics (NASDAQ:VTVT) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Friday, Zacks.com reports. They presently have a $3.25 price target on the biotechnology company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 10.54% from the stock’s current price. VTVT is currently sporting a Zacks Rank of #2 (Buy). Within the past quarter, the Zacks Consensus Estimate for VTVT's full-year earnings has moved 2.50% higher. Zacks Investment Research downgraded shares of vTv Therapeutics (NASDAQ:VTVT) from a buy rating to a sell rating in a research report report published on Tuesday, Zacks.com reports.. According to Zacks, “vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. VTVT is currently sporting a Zacks Rank of #2 (Buy). Within the past quarter, the Zacks Consensus Estimate for VTVT's full-year earnings has moved 2.50% higher. This signals that analyst sentiment 雪球为您提供vTv Therapeutics(VTVT)股票实时行情,资金流向,新闻资讯,研究报告,社区互动,交易信息,个股点评,公告,财务指标分析等与vTv Therapeutics(VTVT)股票相关的信息与服务.

Immunomedics (IMMU) reports a narrower-than-expected Q1 loss. The focus is on its recently approved drug, Trodelvy, for mTNBC. May. 7, 2020 at 11:21 a.m. ET on Zacks.com

Find the latest vTv Therapeutics Inc. (VTVT) stock quote, history, news and other vital information to help you with your stock trading and investing. Immunomedics (IMMU) reports a narrower-than-expected Q1 loss. The focus is on its recently approved drug, Trodelvy, for mTNBC. May. 7, 2020 at 11:21 a.m. ET on Zacks.com View vTv Therapeutics Inc VTVT investment & stock information. Get the latest vTv Therapeutics Inc VTVT detailed stock quotes, stock data, Real-Time ECN,

ARVN Stock Price | Arvinas Inc. Stock Quote ... - MarketWatch

ARVN | Complete Arvinas Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. gubaf10.eastmoney.com (pme)平潭海洋实业 (ptr)中石油 (rcon)研控科技 (renn)人人网 (seed)奥瑞金种业 (sfun)房天下控股 (sgoc)上为集团 (shi)上海石化 (simo)慧荣科技 (sina Pre-Market Stock Quote Data | Nasdaq

FINVIZ.com - Stock Screener

Free Stock Screener – MarketWatch The Intraday Stock Screener is designed to screen for stocks using as many or as few parameters as you wish to define. All parameters default to none. Stock Picks, Stock Market Investing | Seeking Alpha Scotts Miracle-Gro raises full-year earnings, revenue guidance. Scotts Miracle-Gro (NYSE:SMG) +5.5% after-hours after raising its FY 2020 forecast for adjusted EPS to $5.65-5.85 from previous Stock Quotes, Business News and Data from Stock Markets ...

VTVT is currently sporting a Zacks Rank of #2 (Buy). Within the past quarter, the Zacks Consensus Estimate for VTVT's full-year earnings has moved 2.50% higher. This signals that analyst sentiment

Mar 26, 2018 FINVIZ.com - Stock Screener Stock screener for investors and traders, financial visualizations. Outlook Therapeutics, Inc. (OTLK) Stock Price, Quote ... Find the latest Outlook Therapeutics, Inc. (OTLK) stock quote, history, news and other vital information to help you with your stock trading and investing. NVAX Novavax, Inc. — Stock Price and Discussion | Stocktwits Novavax, Inc. NVAX 45.00 1.34 (2.88%). NASDAQ Updated Jun 8, 2020 8:07 PM